| To: ralfph who wrote (129) | 11/25/2000 3:45:26 PM |
| From: .Trev | Read Replies (1) of 134 |
| |
<"Immune Network Ltd - In the News
Van Sun says Immune Network in major HIV deal
Immune Network Ltd IMM
Shares issued 33,114,792 Nov 22 close $0.29
Thu 23 Nov 2000 In the News
The Vancouver Sun reports in its Thursday edition that Immune Network says
it has acquired an "exclusive" licence from a "major" Japanese company for
a new drug candidate to treat HIV infection. Reporter Rod Nutt notes that
the agreement is with Nissin Food Products of Osaka. The antibody, hNMO1,
was first discovered and patented by Nissin's research and development team
at the Nissin Biotechnology Institute in Boston, Mass. The drug candidate
is believed to act by inactivating the HIV virus, which may delay the full
development of AIDS in HIV infected individuals. "Immune Network's approach
to immune-based therapies for HIV, developing multiple agents with varying
mechanisms of action, has great potential for strengthening current
approaches to the treatment of HIV infection," says Dr. Brian Conway, a
"leading physician" in the field of HIV virology and a member of Immune
Network's advisory board. "As such, hNMO1 is an ideal candidate for further
evaluation in clinical trials," he says.
(c) Copyright 2000 Canjex Publishing Ltd. http://www.stockwatch.com ">
iGUESS THIS IS WHAT YOU'RE TALKING ABOUT??????? |
|
